Pavon Anna Giulia, Monney Pierre, Schwitter Juerg
Cardiac MR Center (CRMC), Lausanne University Hospital (CHUV), 1100 Lausanne, Switzerland.
Cardiovascular Department, Division of Cardiology, Lausanne University Hospital (CHUV), 1100 Lausanne, Switzerland.
Diagnostics (Basel). 2021 Apr 10;11(4):683. doi: 10.3390/diagnostics11040683.
Mitral valve prolapse (MVP) was first described in the 1960s, and it is usually a benign condition. However, a subtype of patients are known to have a higher incidence of ventricular arrhythmias and sudden cardiac death, the so called "arrhythmic MVP." In recent years, several studies have been published to identify the most important clinical features to distinguish the benign form from the potentially lethal one in order to personalize patient's treatment and follow-up. In this review, we specifically focused on for increased arrhythmic risk to whom the cardiologist must be aware of while performing a cardiovascular imaging evaluation in patients with MVP.
二尖瓣脱垂（MVP）于20世纪60年代首次被描述，通常为良性疾病。然而，已知有一部分患者发生室性心律失常和心源性猝死的几率较高，即所谓的“心律失常性MVP”。近年来，已发表了多项研究以确定区分良性形式与潜在致命形式的最重要临床特征，从而实现患者治疗和随访的个体化。在本综述中，我们特别关注了在对MVP患者进行心血管成像评估时，心脏病专家必须意识到的心律失常风险增加的情况。
